Biofil Chemicals & Pharmaceuticals Ltd.

Financial

	Biofil Chem & Pharma	Makers Laboratories	Ind-Swift
Operational Metrics
Financials
5 yr Average ROE	5.42 %	-2.26 %	13.04 %
5yr average Equity Multiplier	2.09	2.42	-0.95
5yr Average Asset Turnover Ratio	0.96	0.68	0.57
5yr Avg Net Profit Margin	2.86 %	-1.82 %	-31.25 %
Price to Book	4.57	1.24	0.0
P/E	138.8	14.07	1.23
5yr Avg Cash Conversion Cycle	65.55 Days	81.6 Days	-141.81 Days
Inventory Days	25.38 Days	108.24 Days	64.0 Days
Days Receivable	244.02 Days	69.51 Days	88.62 Days
Days Payable	179.27 Days	109.89 Days	283.86 Days
5yr Average Interest Coverage Ratio	21.93	3.06	-4.31
5yr Avg ROCE	7.69 %	4.88 %	-53.05 %
5yr Avg Operating Profit Margin	4.5 %	7.75 %	1.75 %
5 yr average Debt to Equity	0.04	0.25	-1.52
5yr CAGR Net Profit	-10.11 %	80.14 %	n/a
5yr Average Return on Assets	2.72 %	-0.95 %	-12.25 %
Shareholdings
Promoter Holding	46.82 %	61.27 %	55.58 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	2.9 %	0.03 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Biofil Chem & Pharma	Makers Laboratories	Ind-Swift
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 75.52 Chemicals 24.48 Services 0 Chemicals 0 Generic Formulation 0 Sales of APIs 0	Product Wise Break-Up Chemicals 52.71 Services 7.75 Sales of APIs 0 Pharmaceuticals 0 Formulation 39.53 Others 0.01	Product Wise Break-Up Chemicals 0 Services 0 Active Pharmaceutical Ingredient (API) 100.0 Pharmaceuticals 0 Generic Formulation 0
Operating Profit Break-Up	Operating Profit Break-Up Chemicals 100.0 Pharma Div 0 Chemical 0 Pharmaceutical 0	Operating Profit Break-Up Chemical 100.0 Pharma Div 0 Pharmaceutical 0 Chemicals 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise Chemical 51.42 Pharma 48.58	-	-